3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
22
Rectal Neoplasms
8
Colonic Neoplasms
7
Neoplasms
5
Neoplasm Metastasis
3
Ovarian Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Exanthema
1
Colorectal Cancer Metastatic
1
Carcinoma, Basal Cell
1
Advanced Solid Tumor
1
Adenocarcinoma
1
Interventions
benralizumab
1
Triamcinolone Acetonide
1
Tetracycline
1
Sirolimus
1
Panitumumab
1
Minocycline
1
Irinotecan
1
IFL protocol
1
Hydrocortisone
1
Gels
1
Fulvestrant
1
Erlotinib Hydrochloride
1
Dapsone
1
Clindamycin
1
Anti-Bacterial Agents
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Exanthema
×
IFL protocol
×
Clear all
NCT00332163
2016-02-23
STEPP
Amgen
Phase 2
Completed
95 enrolled
23 charts